Product OverviewIMD-L rapidly synthesizes nanomedicines such as lipid nanoparticles (LNP), liposomes and bio-nano pesticides. Based on microfluidic technology with automated operation, it controls sample particle size and ensures consistent key parameters across parallel experiments. Suitable for laboratory formulation screening and process scale-up.
ApplicationUsed for formulation optimization and scale-up of nanodrug delivery processes; intended for laboratory use. Flow rate: 0.01 ml/min - 100 ml/min. Synthesis volume: 1 ml - 50 ml.
Easy-to-operateAutomatic sample loading, automatic cleaning, recipe calling and data recording streamline experiments and reduce manual error.
Stable Performance with Small Batch VarianceDesigned to maintain consistent particle size and low batch-to-batch variance in parallel experiments, facilitating reliable screening and process validation.
mRNA-LNP Particle DistributionParallel experiment | First Time | Second Time | Third Time
Mean Particle Size (PDI) | 86.12 nm (0.062) | 81.87 nm (0.031) | 82.91 nm (0.003)
Features / Technical specifications- Model: IMD-L
- Intended products: lipid nanoparticles (LNP), liposomes, bio-nano pesticides and other nanomedicines
- Flow rate range: 0.01 ml/min - 100 ml/min
- Synthesis volume (per run): 1 ml - 50 ml
- Automatic functions: sample loading, automatic cleaning, recipe calling, data recording
- Suitable uses: laboratory formulation screening, process scale-up
- Performance: precise particle size regulation and stable batch variance (see mRNA-LNP distribution data)